Condition 1: Schizophrenia disorder. Condition 2: bipolar disorder. Condition 3: Major deppresion disorder. Schizophrenia Bipolar affective disorder Depressive episode
Conditions
Interventions
Intervention 1: Intervention group:Famotidine 40 mg tablet,one tablet daily, for two months. Intervention 2: Control group: oral placebo tablets,one tablet daily,for two months.
Treatment - Drugs
Intervention group:Famotidine 40 mg tablet,one tablet daily, for two months
Control group: oral placebo tablets,one tablet daily,for two months
Sponsors
Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Patients 20 to 55 years with psychiatric disorders; Non-pregnant;No history of medical conditions increase weight Exclusion criteria: Patients who have serious health problems including liver or kidney disease;Use of other medications with potential weight gain ; Patients who have a body mass index greater than 30
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight.BMI. Timepoint: week 0,2,4,6,8 during intervention. Method of measurement: Weight, balance(kg),BMI,The ratio of weight to height squared. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArman Zarghami
Ahvaz Jundishapur of Medical Science
Outcome results
None listed